20 years helping business leaders deliver alpha. View our success stories
20 years helping business leaders deliver alpha. View our success stories
By Humatica
As the fall-out from COVID-19 threatens to sink entire portfolios, PE sponsors and CEO’s need to walk a tightrope between preserving organisational capabilities in order to resume growth in case of a rebound in 2H 2020, while at the same time preparing to survive a protracted recession or even depression if things go wrong.
Our latest HumaticaCorner explores the options for portfolio managers and CEOs.
This is the final article in a three-part series on designing and implementing a fit-for-purpose Target Operating Model. In Part I, we explored how to…
Read more
For the past three years, the AI conversation in business has been primarily about AI as an assistant — a tool that helps humans work…
Read more
One of the most persistent sources of confusion in business conversations about AI is the habit of treating ‘AI’ as a single, monolithic technology. It…
Read more
Erhalten Sie jeden Monat Neuigkeiten und wertvolle Perspektiven zu Themen der organisatorischen Effektivität
